Cecilia Larocca

Cecilia Larocca, M.D., is an Assistant Professor of Dermatology at Brigham and Women's Hospital, specializing in Dermatology and Oncology. Her research focuses on cutaneous T-cell lymphoma, dermatologic adverse events from cancer therapies, and immunotherapy applications in skin diseases.

• Key Research Areas:
  • Cutaneous T-cell lymphoma (Mycosis Fungoides, Sézary Syndrome)
  • Dermatologic toxicities from immune checkpoint inhibitors and targeted therapies
  • Development of clinical guidelines for disease management
• Notable Collaborations:
  • Collaborates with experts like Nicole Leboeuf, Thomas Kupper, and Andrew Lane
  • Participates in international consensus initiatives (IDEOM)

Dr. Larocca's recent publications address topics such as low-dose alemtuzumab outcomes, FACT-CTCL quality-of-life assessments, and management of drug-induced skin eruptions. Her work bridges clinical practice, patient-centered outcomes, and immunological mechanisms in skin malignancies.

Selected Trends in Research:

• Immune system modulation in T-cell lymphomas
• Quality-of-life metrics in chronic skin cancers
• Consensus-driven dermatological standards
• Toxicity management in combined cancer therapies